Boehringer Banks On Cancer For Future Growth
The privately held company has spent the last 20 years building an oncology franchise, based largely on platform deals and in-house R&D.
The privately held company has spent the last 20 years building an oncology franchise, based largely on platform deals and in-house R&D.